DE69026497D1 - Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür - Google Patents

Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür

Info

Publication number
DE69026497D1
DE69026497D1 DE69026497T DE69026497T DE69026497D1 DE 69026497 D1 DE69026497 D1 DE 69026497D1 DE 69026497 T DE69026497 T DE 69026497T DE 69026497 T DE69026497 T DE 69026497T DE 69026497 D1 DE69026497 D1 DE 69026497D1
Authority
DE
Germany
Prior art keywords
dvma
acid
vma
antibody
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69026497T
Other languages
English (en)
Other versions
DE69026497T2 (de
Inventor
Manami Kuroda
Masahito Sugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Publication of DE69026497D1 publication Critical patent/DE69026497D1/de
Application granted granted Critical
Publication of DE69026497T2 publication Critical patent/DE69026497T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69026497T 1989-10-19 1990-10-18 Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür Expired - Fee Related DE69026497T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27253889 1989-10-19
PCT/JP1990/001344 WO1991006005A1 (fr) 1989-10-19 1990-10-18 Procede de titrage de l'acide d-vanillylmandelique, et reactif et kit utilises

Publications (2)

Publication Number Publication Date
DE69026497D1 true DE69026497D1 (de) 1996-05-15
DE69026497T2 DE69026497T2 (de) 1996-08-22

Family

ID=17515291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69026497T Expired - Fee Related DE69026497T2 (de) 1989-10-19 1990-10-18 Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür

Country Status (8)

Country Link
US (1) US5298397A (de)
EP (1) EP0450095B1 (de)
JP (1) JPH0782015B2 (de)
AT (1) ATE136650T1 (de)
AU (1) AU638500B2 (de)
CA (1) CA2044154C (de)
DE (1) DE69026497T2 (de)
WO (1) WO1991006005A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1390484A4 (de) * 2001-05-30 2005-01-26 Paradigm Genetics Inc Verfahren zur identifizierung von inhibitoren der expression oder aktivität von pektinesterase in pflanzen
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
CN105175530A (zh) * 2015-08-14 2015-12-23 苏州博源医疗科技有限公司 一种香草扁桃酸免疫检测试剂及其制备方法
CN107353200A (zh) * 2017-06-27 2017-11-17 苏州博源医疗科技有限公司 一种香草扁桃酸衍生物、其合成方法及一种香草扁桃酸免疫原、其制备方法及其应用
CN114956997B (zh) * 2022-03-30 2022-12-16 北京丹大生物技术有限公司 香草扁桃酸半抗原衍生物及其合成方法，香草扁桃酸抗原及其制备方法，抗体及试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123765A (ja) * 1983-12-07 1985-07-02 Yamaguchiken バニルマンデリック酸に対する特異抗体の製造方法
JPH061271B2 (ja) * 1985-02-27 1994-01-05 ヤマサ醤油株式会社 カテコ−ルアミンの酸性代謝物に対する抗体の製造法およびそれに使用する抗原
JP3000810B2 (ja) * 1993-01-19 2000-01-17 日産自動車株式会社 車両のフロア構造

Also Published As

Publication number Publication date
EP0450095A1 (de) 1991-10-09
AU6532390A (en) 1991-05-16
EP0450095A4 (de) 1991-08-07
JPH0782015B2 (ja) 1995-09-06
EP0450095B1 (de) 1996-04-10
AU638500B2 (en) 1993-07-01
WO1991006005A1 (fr) 1991-05-02
ATE136650T1 (de) 1996-04-15
CA2044154C (en) 1999-07-13
CA2044154A1 (en) 1991-04-20
DE69026497T2 (de) 1996-08-22
US5298397A (en) 1994-03-29

Similar Documents

Publication Publication Date Title
ATE113723T1 (de) Verfahren zur bestimmung von antikörpern.
ATE297950T1 (de) Testverfahren und reagenzien zur quantifizierung von hbnp
DE3882040D1 (de) Verfahren und vorrichtungen zur durchfuehrung von untersuchungen.
DE3577230D1 (de) Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer.
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
DK314987D0 (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
DE69231559D1 (de) Reagenzien und verfahren zur quantifizierung des totalgehaltes an doxepinen in biologischen flüssigkeiten
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
ATE111533T1 (de) Verfahren zur bestimmung von nukleinsäuren.
ES2079368T3 (es) Metodo y reactivos para detectar anfetaminas y/o d-meta-anfetaminas en muestras biologicas.
DE69026497D1 (de) Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
DE3584023D1 (de) Verfahren zur durchfuehrung von immunfluoreszenztesten.
DE59108366D1 (de) Verfahren zur Bestimmung eines Analyten
ATA193888A (de) Verfahren zur quantitativen bestimmung des zustandes oder von zustandsaenderungen von inhomogenen proben
DE3669078D1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ATE88571T1 (de) Immunologischer testkit.
ATE146595T1 (de) Verfahren zur bestimmung einer immunologisch bindefähigen substanz
KR880700270A (ko) 검체의 발광을 이용하여 검체가 존재가능한 매질에서 검체를 검출 및/또는 측정하기 위한 단상 방법
ATE80948T1 (de) Diagnostisches immuntest-verfahren mittels festphasenabscheidung.
FR2348494A1 (fr) Procede de mesure de la teneur en acides biliaires dans un echantillon, a l'aide de derives d'acide biliaire conjugues, marques, et les derives correspondants
ATE150177T1 (de) Verfahren zur bestimmung von autoantikörpern in biologischen flüssigkeiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee